Skip to main content
Premium Trial:

Request an Annual Quote

Columbia University Sues Illumina

The trustees of Columbia University have filed a lawsuit claiming that Illumina is infringing on five of the school's gene-sequencing patents, reports Bloomberg News. The suit was filed in federal court in Wilmington, Del., and concerns patents awarded in 2009 on technologies developed by Columbia's Jingyue Ju and colleagues for rapid DNA sequencing, Reuters adds. Columbia has asked for damages and an injunction. "Columbia is proud of the outstanding research efforts of its faculty and will defend its patented technology," university spokesperson Robert Hornsby tells Reuters.

Illumina's Jennifer Temple tells Bloomberg that "we believe these claims are without merit, and we will defend against them vigorously."

Our sister publication GenomeWeb Daily News has more on this suit here.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.